Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Rev Soc Bras Med Trop ; 38 Suppl 2: 87-91, 2005.
Artigo em Espanhol | MEDLINE | ID: mdl-16482823

RESUMO

Trypanosoma cruzi induces changes in the protein pattern of human placenta syncytiotrophoblast. Placental alkaline phosphatase (PLAP) is a glycoenzyme anchored to the membrane by a glycosyl-phosphatidylinositol molecule. PLAP activity and its presence was altered by the parasite in cultures of human placental villi and HEp2 cells with T.cruzi. The cells treated before the cultures with agents which affect PILAP or glycosyl-phosphatidylinositol (antibodies, PL-C, genistein, lithium) presented less parasitic invasion than the control ones. It was also observed a modification in the pattern of actine filaments of the host cells infected. We concluded that PLAP would participate in the process of T. cruzi invasion into placental syncitiotrophoblast cells, by a mechanism that involves hydrolysis of the glycosyl-phosphatidylinositol molecules, the activation of tyrosine kinase proteins, the increase of cytosolic calcium and the rearrangement of actine filaments of the host cells.


Assuntos
Fosfatase Alcalina/metabolismo , Doença de Chagas/enzimologia , Placenta/enzimologia , Trypanosoma cruzi/fisiologia , Fosfatase Alcalina/análise , Análise de Variância , Animais , Biomarcadores , Técnicas de Cultura de Células , Doença de Chagas/imunologia , Doença de Chagas/parasitologia , Vilosidades Coriônicas/enzimologia , Vilosidades Coriônicas/parasitologia , Feminino , Glicosilfosfatidilinositóis/metabolismo , Humanos , Imuno-Histoquímica , Placenta/parasitologia , Gravidez , Trofoblastos/enzimologia , Trofoblastos/parasitologia
2.
Rev Soc Bras Med Trop ; 38(1): 53-5, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15717095

RESUMO

We studied three pregnant women with acute chagasic infection. Two patients, infected in the third trimester of pregnancy, had uninfected children. The third patient, infected earlier, had an infected newborn. These results encourage research on risk factors of transmission and on medical decisions concerning pregnant women with acute Chagas' disease.


Assuntos
Doença de Chagas/transmissão , Transmissão Vertical de Doenças Infecciosas , Complicações Parasitárias na Gravidez , Doença Aguda , Adolescente , Adulto , Doença de Chagas/congênito , Feminino , Humanos , Recém-Nascido , Masculino , Nitroimidazóis/uso terapêutico , Gravidez , Complicações Parasitárias na Gravidez/parasitologia , Primeiro Trimestre da Gravidez , Terceiro Trimestre da Gravidez , Fatores de Risco , Tripanossomicidas/uso terapêutico
3.
J Trop Med ; 2012: 969243, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-21941569

RESUMO

Trypanosoma cruzi, the etiologic Chagas' disease agent, induces changes in protein pattern of the human placenta syncytiotrophoblast. The glucose transporter protein-1 (GLUT1) is the primary isoform involved in transplacental glucose transport. We carried out in vitro assays to determine if T. cruzi infection would induce changes in placental GLUT1 protein expression under normal and high concentration of glucose. Using Western blot and immunohistological techniques, GLUT1 expression was determined in normal placental villi cultured under normal or high concentrations of glucose, with or without in vitro T. cruzi infection, for 24 and 48 hours. High glucose media or T. cruzi infection alone reduced GLUT1 expression. A yet more accentuated reduction was observed when infection and high glucose condition took place together. We inform, for the first time, that T. cruzi infection may induce reduction of GLUT1 expression under normal and high glucose concentrations, and this effect is synergic to high glucose concentrations.

4.
Rev. Soc. Bras. Med. Trop ; 38(1): 53-55, jan.-fev. 2005. ilus
Artigo em Inglês | LILACS | ID: lil-420214

RESUMO

Se descrevem 3 gestantes com a doença de Chagas aguda. Duas gestantes infetadas no 3º trimestre de gestação não tiveram crianças infetadas. O 3º filho, doquella madre foi infetada no 1º trimestre, nasceu com doença de Chagas congénita. Estes resultados inducem a investigação sobre os fatores de riscos da transmição e sobre as desições médicas na conducção dos casos de gestantes com a doença de Chagas aguda.


Assuntos
Adolescente , Adulto , Feminino , Humanos , Recém-Nascido , Masculino , Gravidez , Doença de Chagas/transmissão , Transmissão Vertical de Doenças Infecciosas , Complicações Parasitárias na Gravidez , Doença Aguda , Doença de Chagas/congênito , Nitroimidazóis/uso terapêutico , Primeiro Trimestre da Gravidez , Terceiro Trimestre da Gravidez , Complicações Parasitárias na Gravidez/parasitologia , Fatores de Risco , Tripanossomicidas/uso terapêutico
5.
Rev. Fac. Cienc. Méd. (Córdoba) ; 55(1/2): 5-8, 1997. tab, graf
Artigo em Inglês | LILACS | ID: lil-231895

RESUMO

The Kinetic properties of plasma placental alkaline phosphatase patients with Chagas' disease were studied. When Cl2 Mg was used as activator the same increase of activity (17-20 per cent) was found in the chagasic and non chagasic groups. The enzyme was not inhibited by F-ion in any of the groups. No significant differences were detected between the two groups (chagasic and non chagasic) when the enzyme was treated with inhibitors such as EDTA and L-phenylamine. However, when the CN- ion was used, the enzyme of the normal pregnant women followed a Michaelian curve, whereas in the chagasic group a sigmoideal plot was observed. Thus, the Hill coefficient was 1.1 for the normal group and over 1.5 for the chagasic.


Assuntos
Adulto , Feminino , Humanos , Gravidez , Fosfatase Alcalina/sangue , Doença de Chagas/enzimologia , Ácido Edético , Placenta/enzimologia , Complicações Parasitárias na Gravidez/enzimologia , Fosfatase Alcalina/efeitos dos fármacos , Fosfatase Alcalina/metabolismo , Doença de Chagas/sangue , Ácido Edético , Inibidores Enzimáticos/farmacologia , Reativadores Enzimáticos/farmacologia , Complicações Parasitárias na Gravidez/sangue , Terceiro Trimestre da Gravidez
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA